Olav Engebraaten

Oslo University Hospital — Norway

Biochemistry, Genetics and Molecular Biology · Life Sciences

33h-index3.8kcitations153works1.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Breast Cancer Treatment Studies(28), Cancer Genomics and Diagnostics(25), Cancer Treatment and Pharmacology(20), HER2/EGFR in Cancer Research(18), Cancer Cells and Metastasis(17)

Publications153 total

The harmonized activities of HER2–HER3 heterodimer and deacetylated FOXA1 evade hormone response by regulating FOXA1 chromatin binding
Nucleic Acids Research·2025Open Access
Spatial organization of the tumor-immune microenvironment in ER-positive breast cancer: remodeling during treatment and associations with clinical response
2025Open Access
High mid-treatment tumour RNA disruption in patients with HER2-negative breast cancer is associated with improved disease-free survival after neoadjuvant chemotherapy
Breast Cancer Research·2025· 1 citedOpen Access
Randomised trial of trastuzumab deruxtecan and biology-driven selection of neoadjuvant treatment for HER2-positive breast cancer: a study protocol of ARIADNE
BMJ Open·2025· 1 citedOpen Access
Chemoresistant tumor cell secretome potentiates immune suppression in triple negative breast cancer
Breast Cancer Research·2025Open Access
Abstract P2-01-26: Carboplatin added to neoadjuvant chemotherapy in a randomized phase II study: Complex DNA based biomarkers predict response in hormone receptor positive and triple negative breast cancer
Clinical Cancer Research·2025
Abstract 3104: The mechanism of action of ADCs are dependent on Rab GTPases
Cancer Research·2025
Abstract 3307: Utilizing endocytosis as a predictive biomarker for ADCs
Cancer Research·2025
The mechanisms of HER2 targeted ADCs are dependent on Rab GTPases
Therapeutic Advances in Medical Oncology·2025· 1 citedOpen Access
The SRC-family serves as a therapeutic target in triple negative breast cancer with acquired resistance to chemotherapy
British Journal of Cancer·2024· 9 citedOpen Access
Impact of Prosigna test on adjuvant treatment decision in lymph node-negative early breast cancer—a prospective national multicentre study (EMIT-1)
ESMO Open·2024· 11 citedOpen Access
An integrated omics approach highlights how epigenetic events can explain and predict response to neoadjuvant chemotherapy and bevacizumab in breast cancer
Molecular Oncology·2024· 4 citedOpen Access
260 ViRP signature predicts response to treatment with chemotherapy and bevacizumab in ovarian cancer – a translational study of the ICON-7 trial’
2024
Author response for "An integrated omics approach highlights how epigenetic events can explain and predict response to neoadjuvant chemotherapy and bevacizumab in breast cancer"
2024
Explainable Machine Learning Reveals the Role of the Breast Tumor Microenvironment in Neoadjuvant Chemotherapy Outcome
2023· 4 citedOpen Access
Liver X receptors induce antiproliferative effects in basal‐like breast cancer
Molecular Oncology·2023· 3 citedOpen Access
Author response for "Liver X receptors induce antiproliferative effects in basal‐like breast cancer"
2023
Abstract 2170: Pre-treatment protein landscape in HER2-negative breast cancer treated with carboplatin in a neoadjuvant chemotherapy setting
Cancer Research·2023
Abstract 5627: Spatial protein profiling by cyclic immunofluorescence to interpret and improve bulk tumor-based predictor of response to chemotherapy with bevacizumab in neoadjuvant breast cancer treatment
Cancer Research·2023
Abstract 4675: Chemoresistant patient-derived xenografts to identify treatment options in breast cancer patients not responding to standard chemotherapy
Cancer Research·2023
page 1 of 8Next →

Frequent Co-authors

Gunhild M. Mælandsmo(13), Øystein Fodstad(13), Anne‐Lise Børresen‐Dale(10), Bjørn Naume(9), Elin Borgen(9), Øystein Garred(8), Rolf Bjerkvig(7), Evita M. Lindholm(7), Vessela N. Kristensen(6), Geir Olav Hjortland(6), Siri Juell(6), Morten Lund‐Johansen(5), Ole Didrik Lærum(5), Thomas Fleischer(5), Tone F. Bathen(5), Ole Christian Lingjærde(5), Laxmi Silwal‐Pandit(5), Siver Andreas Moestue(5), Ingrid S. Gribbestad(5), Thérese Sørlie(4)